Biostadt India Limited
Biostadt India Limited is a Public Non-govt company company incorporated in 2003 and based in Maharashtra, India. Biostadt India Limited operates in Pharmaceuticals & Chemicals (NIC 24210) with authorized capital of ₹4.05 Cr and paid-up capital of ₹3.30 Cr. For 2023-24, the company reported revenue of ₹766.85 Cr and profit after tax of ₹46.54 Cr. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Biostadt India Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 25 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +37d | filed |
| MGT-7 | FY2023-24 | 24 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 26 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Biostadt India Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 638428723 | ICICI Bank Ltd(Bank) | ₹1.54 Cr | 12 Mar 2023 | Satisfied |
| 942229101 | State Bank of India(Bank) | ₹56.00 L | 27 Jan 2019 | Satisfied |
| 780593793 | Kotak Mahindra Bank Ltd(Bank) | ₹20.99 Cr | 04 Jul 2020 | Open |
| 181621432 | ICICI Bank Ltd(Bank) | ₹22.12 Cr | 04 Jul 2022 | Satisfied |
| 721242903 | HDFC Bank Ltd(Bank) | ₹6.57 Cr | 04 Jul 2019 | Open |
Charge IDs, lenders & amounts for Biostadt India Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2023-24 | — | ||||
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2019-20 | — | ||||
| 2018-19 | — | ||||
| 2017-18 | — | ||||
| 2015-16 | — | ||||
| 2014-15 | — |
Detailed Financials
4 FYs| Line item | 2023-24 | 2022-23 | 2021-22 | 2020-21 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2023-24 | -9.0% | -4.0% | +1.0% | |
| Profit after Tax2023-24 | -6.0% | -54.0% | +16.0% | |
| Net Worth2023-24 | +73.0% | +15.0% | +58.0% |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2014-15 | +5.70% | — | +18.14% | +9.41% | — | |||
| 2015-16 | +4.98% | +11.84% | +16.13% | +8.79% | — | |||
| 2017-18 | +6.18% | +29.43% | +21.13% | +9.56% | — | |||
| 2018-19 | +3.52% | +6.78% | +11.99% | +5.01% | — | |||
| 2019-20 | +6.01% | +8.21% | +20.30% | +9.05% | — | |||
| 2020-21 | +9.98% | +12.04% | +28.64% | +13.83% | — | |||
| 2021-22 | +6.82% | -5.38% | +16.53% | +8.20% | 1.01 | |||
| 2022-23 | +5.89% | -1.31% | +12.33% | +6.61% | 0.87 | |||
| 2023-24 | +6.07% | -7.64% | +10.51% | +6.10% | 0.72 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 1,45,03,867 | 55.18% |
| Institutional Investors | 3 | 45,77,014 | 17.41% |
| Public & Others | 49 | 72,04,679 | 27.41% |
Promoter, institutional & public holding for Biostadt India Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
89 peersEvents & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.